Cruxta

XENENASDAQ| Xenon Pharmaceuticals golden cross and death cross

XENE is projected to death cross on the daily within 20 bars. On the daily chart the 50 SMA has sat above the 200 since Sep 2025, but price is now trading below both, and the two averages have been closing on each other.

On the daily, XENE has crossed 21 times, roughly every 5 months, the last one on 9/25/2025. On the weekly it has crossed 2 times, most recently a golden cross in Mar 2026, with price trading above the 50/200 cross point that day. It closed the following week 1% lower.

On the 4-hour chart a death cross is projected within 10 bars, which is the nearest-term signal here.

XENE  

Loading the chart...

XENE cross history: every 50/200 cross since 2018

39 golden and death crosses since 2018, with 2 on the weekly timeframe. Of the 21 daily crosses tracked, we projected 20 of them from a median of 22 bars out. It has not crossed on any timeframe since 3/20/2026.

Crossed
3/20/2026Goldenweekly
2/24/2026Golden4-hour
2/20/2026Death4-hour
2/19/2026Golden4-hour
2/17/2026Death4-hour
9/25/2025Goldendaily
9/19/2025Deathweekly
8/15/2025Golden4-hour
1/24/2025Deathdaily
1/6/2025Death4-hour
11/29/2024Goldendaily
10/2/2024Golden4-hour
9/30/2024Death4-hour
9/30/2024Golden4-hour
9/6/2024Death4-hour
8/1/2024Golden4-hour
6/18/2024Deathdaily
4/12/2024Death4-hour
1/12/2024Goldendaily
12/20/2023Golden4-hour
8/31/2023Deathdaily
7/28/2023Death4-hour
5/12/2023Goldendaily
5/11/2023Deathdaily
5/9/2023Goldendaily
5/3/2023Golden4-hour
4/21/2023Deathdaily
3/20/2023Death4-hour
7/25/2022Goldendaily
7/6/2022Deathdaily
10/6/2021Goldendaily
9/27/2021Deathdaily
1/8/2021Goldendaily
7/30/2020Deathdaily
12/6/2019Goldendaily
10/11/2019Deathdaily
6/4/2019Goldendaily
12/26/2018Deathdaily
3/1/2018Goldendaily

Click any cross on the chart above for its lead time. Crosses from 2 September 2026 onward were watched live; earlier ones are replayed from the archive with no look-ahead, which is the same method behind the published track record.

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.